Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Jean-Michel Molina

Biographic Data

ID8931656
NAMEJean-Michel Molina
GIVEN NAMESJean-Michel
FAMILY NAMEMolina
SIGNATUREMOLINA J
AFFILIATIONSInfectious Diseases Unit, Saint Louis Hospital, Paris, France
VERIFIEDNo
TOTAL WORKS11
TOTAL CITATIONS0
WORKS AS AUTHOR11
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2011
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Trajectories of Chemsex Engagement Across Time Among PrEP-Using Men Who Have Sex with Men

    Emils Sietins, Luis Sagaon-Teyssier et al.•ARTICLE•International Journal of Sexual…•2025

    Objectives To identify trajectories of chemsex engagement and their evolution across time among men who have sex with men (MSM) and the associated factors.Methods Among 2518 PrEP-using MSM in the French ANRS- Prévenir cohort, a group-based trajectory model was used to identify trajectories of chemsex engagement. A multivariable model was then used to estimate time-constant factors associated with trajectory membership, and time-varying factors as…

  • Isisekelo Sempilo study protocol for the effectiveness of HIV prevention embedded in sexual health with or without peer navigator support (Thetha Nami) to reduce prevalence of transmissible HIV amongs…

    Open Access•Glory Chidumwa, Natsayi Chimbindi et al.•ARTICLE•BMC Public Health•2022

    gov Identifier NCT04532307 . Registered: March 2020

  • Perspectives of injectable long acting antiretroviral therapies for HIV treatment or prevention

    Séverine Carillon, Leonor Gallardo et al.•ARTICLE•AIDS Care•2020

    Recent clinical trial data showed that injectable long-acting antiretroviral treatment (LA-ART) every four or eight weeks could become an alternative option for HIV treatment or prevention. The purpose of our study was to explore perceptions and potential users' points of views of this new mode of administration through individuals' therapeutic itinerary and their singular history with ART. Between 2018 and 2019, a qualitative study was conducted…

  • Coverage of Sex Acts by Event-Driven Pre-exposure Prophylaxis

    Open Access•Rebecca Bauer, Emmanuelle Netzer et al.•ARTICLE•AIDS and Behavior•2020

  • The ANRS-Ipergay trial, an opportunity to use qualitative research to understand the perception of the “participant”-physician relationship

    Marion Di Ciaccio, Christel Protière et al.•ARTICLE•AIDS Care•2018

    The ANRS-IPERGAY trial consisted in providing sexual activity-based antiretroviral prophylaxis for HIV prevention (PrEP) with a package of prevention tools (counselling, condoms, HIV and sexually transmitted infections' screening) to highly exposed HIV-negative men who have sex with men (MSM). Few data exist concerning the patient-physician relationship in the particular context of PrEP, where physicians discuss sexual behaviours with MSM who are…

  • Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men

    Open Access•Jean‐michel Molina, Jean-Michel Molina et al.•ARTICLE•The Lancet HIV•2017

  • Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS Ipergay trial

    Open Access•Luis Sagaon-Teyssier, Marie Suzan-Monti et al.•ARTICLE•AIDS Care•2016

    The double-blind phase of the randomized ANRS IPERGAY trial, evaluating sexual activity-based oral HIV pre-exposure prophylaxis (PrEP), was conducted among high-risk men who have sex with men (MSM). Results showed an 86% (95% CI: 40-98) relative reduction in HIV incidence among participants with tenofovir disoproxil fumarate-emtricitabine vs. placebo. The present pooled analysis aimed to analyze (i) participants' adherence to the prescribed treat…

  • On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

    Jean‐michel Molina, Jean-Michel Molina et al.•ARTICLE•New England Journal of Medicine•2015

    BACKGROUND: Antiretroviral preexposure prophylaxis has been shown to reduce the risk of human immunodeficiency virus type 1 (HIV-1) infection in some studies, but conflicting results have been reported among studies, probably due to challenges of adherence to a daily regimen. METHODS: We conducted a double-blind, randomized trial of antiretroviral therapy for preexposure HIV-1 prophylaxis among men who have unprotected anal sex with men. Particip…

  • Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada

    Kevin Robertson, Carmen Bayón et al.•ARTICLE•AIDS Care•2014

    CRANIum, a cross-sectional epidemiology study in Western Europe and Canada, was conducted to describe and compare the prevalence of a positive screen for neurocognitive impairment (NCI), depressive symptoms, and anxiety in an HIV-positive population either receiving combination antiretroviral therapy (cART) or who were naive to antiretroviral therapy (ART). HIV-positive patients ≥18 years of age attending a routine medical follow-up visit and abl…

  • Acceptability of an “on-demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France

    Nicolas Lorente, Lionel Fugon et al.•ARTICLE•AIDS Care•2012

    Although predictors of willingness to take daily, self-administered pre-exposure HIV prophylaxis (PrEP) for men who have sex with men (MSM) have been studied in the context of several PrEP trials internationally, little is known about MSM interested in participating in a trial on the use of PrEP on an "on -demand" basis, i.e., taking a first dose of combined tenofovir/emtricitabine a few hours before possible HIV sexual exposure and a second dose…

  • Correlates of poor perceived health among individuals living with HIV and HBV chronic infections

    Fabienne Marcellin, Karine Lacombe et al.•ARTICLE•AIDS Care•2011

    Chronic hepatitis B virus (HBV) infection affects up to 14% of people living with HIV and AIDS (PLWHA) and is associated with a higher risk of non-AIDS death. While great advances have been made in the therapeutic management of co-infection with HIV and HBV, nothing is known about perceived health in people living with HIV and HBV. This study aimed at characterizing individuals with poor perceived overall health among 308 HIV-HBV co-infected indi…

No prominent works on this page.

  • Correlates of poor perceived health among individuals living with HIV and HBV chronic infections

    Fabienne Marcellin, Karine Lacombe et al.•ARTICLE•AIDS Care•2011

    Chronic hepatitis B virus (HBV) infection affects up to 14% of people living with HIV and AIDS (PLWHA) and is associated with a higher risk of non-AIDS death. While great advances have been made in the therapeutic management of co-infection with HIV and HBV, nothing is known about perceived health in people living with HIV and HBV. This study aimed at characterizing individuals with poor perceived overall health among 308 HIV-HBV co-infected indi…

  • Acceptability of an “on-demand” pre-exposure HIV prophylaxis trial among men who have sex with men living in France

    Nicolas Lorente, Lionel Fugon et al.•ARTICLE•AIDS Care•2012

    Although predictors of willingness to take daily, self-administered pre-exposure HIV prophylaxis (PrEP) for men who have sex with men (MSM) have been studied in the context of several PrEP trials internationally, little is known about MSM interested in participating in a trial on the use of PrEP on an "on -demand" basis, i.e., taking a first dose of combined tenofovir/emtricitabine a few hours before possible HIV sexual exposure and a second dose…

  • Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada

    Kevin Robertson, Carmen Bayón et al.•ARTICLE•AIDS Care•2014

    CRANIum, a cross-sectional epidemiology study in Western Europe and Canada, was conducted to describe and compare the prevalence of a positive screen for neurocognitive impairment (NCI), depressive symptoms, and anxiety in an HIV-positive population either receiving combination antiretroviral therapy (cART) or who were naive to antiretroviral therapy (ART). HIV-positive patients ≥18 years of age attending a routine medical follow-up visit and abl…

  • On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

    Jean‐michel Molina, Jean-Michel Molina et al.•ARTICLE•New England Journal of Medicine•2015

    BACKGROUND: Antiretroviral preexposure prophylaxis has been shown to reduce the risk of human immunodeficiency virus type 1 (HIV-1) infection in some studies, but conflicting results have been reported among studies, probably due to challenges of adherence to a daily regimen. METHODS: We conducted a double-blind, randomized trial of antiretroviral therapy for preexposure HIV-1 prophylaxis among men who have unprotected anal sex with men. Particip…

  • Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS Ipergay trial

    Open Access•Luis Sagaon-Teyssier, Marie Suzan-Monti et al.•ARTICLE•AIDS Care•2016

    The double-blind phase of the randomized ANRS IPERGAY trial, evaluating sexual activity-based oral HIV pre-exposure prophylaxis (PrEP), was conducted among high-risk men who have sex with men (MSM). Results showed an 86% (95% CI: 40-98) relative reduction in HIV incidence among participants with tenofovir disoproxil fumarate-emtricitabine vs. placebo. The present pooled analysis aimed to analyze (i) participants' adherence to the prescribed treat…

  • Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men

    Open Access•Jean‐michel Molina, Jean-Michel Molina et al.•ARTICLE•The Lancet HIV•2017

  • The ANRS-Ipergay trial, an opportunity to use qualitative research to understand the perception of the “participant”-physician relationship

    Marion Di Ciaccio, Christel Protière et al.•ARTICLE•AIDS Care•2018

    The ANRS-IPERGAY trial consisted in providing sexual activity-based antiretroviral prophylaxis for HIV prevention (PrEP) with a package of prevention tools (counselling, condoms, HIV and sexually transmitted infections' screening) to highly exposed HIV-negative men who have sex with men (MSM). Few data exist concerning the patient-physician relationship in the particular context of PrEP, where physicians discuss sexual behaviours with MSM who are…

  • Perspectives of injectable long acting antiretroviral therapies for HIV treatment or prevention

    Séverine Carillon, Leonor Gallardo et al.•ARTICLE•AIDS Care•2020

    Recent clinical trial data showed that injectable long-acting antiretroviral treatment (LA-ART) every four or eight weeks could become an alternative option for HIV treatment or prevention. The purpose of our study was to explore perceptions and potential users' points of views of this new mode of administration through individuals' therapeutic itinerary and their singular history with ART. Between 2018 and 2019, a qualitative study was conducted…

  • Coverage of Sex Acts by Event-Driven Pre-exposure Prophylaxis

    Open Access•Rebecca Bauer, Emmanuelle Netzer et al.•ARTICLE•AIDS and Behavior•2020

  • Isisekelo Sempilo study protocol for the effectiveness of HIV prevention embedded in sexual health with or without peer navigator support (Thetha Nami) to reduce prevalence of transmissible HIV amongs…

    Open Access•Glory Chidumwa, Natsayi Chimbindi et al.•ARTICLE•BMC Public Health•2022

    gov Identifier NCT04532307 . Registered: March 2020

  • Trajectories of Chemsex Engagement Across Time Among PrEP-Using Men Who Have Sex with Men

    Emils Sietins, Luis Sagaon-Teyssier et al.•ARTICLE•International Journal of Sexual…•2025

    Objectives To identify trajectories of chemsex engagement and their evolution across time among men who have sex with men (MSM) and the associated factors.Methods Among 2518 PrEP-using MSM in the French ANRS- Prévenir cohort, a group-based trajectory model was used to identify trajectories of chemsex engagement. A multivariable model was then used to estimate time-constant factors associated with trajectory membership, and time-varying factors as…

HIV/AIDS Research and Interventions (11 works) · Medicine (11 works) · Family medicine (8 works) · Men who have sex with men (8 works) · Pre-exposure prophylaxis (7 works) · HIV, Drug Use, Sexual Risk (5 works) · Demography (4 works) · Environmental health (4 works) · Psychology (4 works) · Syphilis (4 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae